APRINOIA Therapeutics Established Collaboration on Tau PET Ima...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TAIPEI, Dec. 16, 2020 /PRNewswire-AsiaNet/ -- APRINOIA Therapeutics Inc. today announced that they had executed a worldwide non-exclusive licensing agreement for Biogen Inc. (Nasdaq: BIIB) to access APRINOIA's positron emission tomography (PET) imaging tracer, [18F]-APN-1607, for neurodegener...
Authors: LATEST ASIANET NEWS RELEASES